|
2010
|
Invention
|
New method of calculating areas. The present invention relates to a method of determining surface... |
|
|
Invention
|
Piperidine and piperazine derivatives as smo antagonists. The present invention relates to compou... |
|
|
Invention
|
N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase.
N-substituted 5-hydro... |
|
|
Invention
|
Neuromedin u receptor agonists and uses thereof. Neuromedin U receptor agonists for use in the tr... |
|
|
Invention
|
Neuromedin u receptor agonists. Neuromedin U receptor agonists comprising neuromedin U or derivat... |
|
|
Invention
|
Pyrrolopyridine therapeutic compounds. The present invention relates to pyrrolopyridine compounds... |
|
|
Invention
|
Antiviral agents. Compounds of structural formula (I): and pharmaceutically acceptable salts ther... |
|
|
Invention
|
Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections. ... |
|
|
Invention
|
Unsaturated bicyclic heterocyclic derivatives as smo antagonists. The present invention relates t... |
|
2009
|
Invention
|
Method for introducing diversity into and assembly of polynucleotide sequences. The invention pro... |
|
|
Invention
|
Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use. The ... |
|
|
Invention
|
Nucleoside derivatives as inhibitors of viral polymerases. Compounds of structural formula (I): a... |
|
|
Invention
|
Saturated bicyclic heterocyclic derivatives as smo antagonists. The present invention relates to ... |
|
|
Invention
|
Minigene comprising htpa signal peptide, t-cell epitopes, e. coli ltb and furin sensitive linkers... |
|
|
Invention
|
1,2,4-oxadiazole substituted piperidine and piperazine derivatives as smo antagonists. The presen... |
|
|
Invention
|
Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors. The present invention relates t... |
|
|
Invention
|
Compounds, compositions, and methods useful for modulating the expression of histone deacetylase ... |
|
|
Invention
|
Tricyclic derivatives as inhibitors of poly(adp-ribose)polymerase (parp). The present invention r... |
|
|
Invention
|
Oxyntomodulin analogs. Peptide analogs of oxyntomodulin (OXM, glucagon-37), which have been modif... |
|
|
Invention
|
Therapeutic compounds. A class of macrocyclic compounds of formula (I), wherein R1, R3, R4, Ra, R... |
|
2008
|
Invention
|
3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease. T... |
|
|
Invention
|
Pyridazinone derivatives as parp inhibitors. The present invention relates to compounds of formul... |
|
|
Invention
|
Cholesterol derivatives of inhibitors of viral fusion. The present invention relates to compounds... |
|
|
Invention
|
Nucleoside derivatives as inhibitors of viral polymerases. A class of nucleoside derivatives of f... |
|
|
Invention
|
Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase ... |
|
|
Invention
|
Macrocyclic compounds as antiviral agents. A class of macrocyclic compounds offormula (I), wherei... |
|
|
Invention
|
Macrocyclic indole derivatives for the treatment of hepatitis c infections. A class of macrocycli... |
|
|
Invention
|
Apoa-1 peptide mimetics. The invention relates to peptide mimetics for treating disorders associa... |
|
|
Invention
|
T-cell peptide epitopes from carcinoembryonic antigen, immunogenic analogs, and uses thereof. The... |
|
|
Invention
|
Antiviral agents.
A compound of formula (I) and pharmaceutically acceptable salts thereof; compo... |
|
2007
|
Invention
|
4-oxo-4,5-dihydropyrrolo[1,2-a)quinoxaline derivatives as inhibitors of poly(adp-ribose) polymera... |
|
|
Invention
|
Pentacyclic indole derivatives as antiviral agents. 2, W, X, Y and Z are defined herein, and phar... |
|
|
Invention
|
Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inh... |
|
2006
|
Invention
|
Tetracyclic indole derivatives as antiviral agents.
The present invention relates to tetracyclic... |
|
|
Invention
|
Thienopyrroles as antiviral agents. The present invention relates to tetracyclic thienopyrrole co... |
|
|
Invention
|
Method for shielding functional sites or epitopes on proteins.
Methods of site-specifically shie... |
|
2004
|
Invention
|
Hcv replicons containing ns5b from genotype 2b. The present invention features methods for enhanc... |
|
|
Invention
|
Thienopyrroles as antiviral agents. 1 are as defined herein, and pharmaceutically acceptable salt... |
